Login to Your Account

Prequalification status issued for Shantha's pentavalent vaccine

By Cornelia Zou
Staff Writer

Wednesday, May 14, 2014

HONG KONG – Four years after it was sidelined, a pentavalent vaccine produced by the Indian arm of Sanofi Pasteur (the vaccine division of Sanofi SA) – Shantha Biotechnics Ltd. – received prequalification status from the World Health Organization. The prequalification means that United Nations agencies like UNICEF can now purchase the vaccine for use across its programs, mostly in emerging countries.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription